MedPath

LACTATED RINGER'S AND 5% DEXTROSE INJECTION, USP

LACTATED RINGER'S AND 5% DEXTROSE INJECTION, USP

Approved
DIN Number

00061131

Drug Class

Human

Market Date

Dec 31, 1973

Company
HC

baxter corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00061131
AIG Number0500106006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B05BB02 ELECTROLYTES WITH CARBOHYDRATES
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification40:12.00
Health Canada Classification

ACTIVE INGREDIENTS (5)

CALCIUM CHLORIDEActive
Strength: 20 MG / 100 ML
Monograph: CALCIUM CHLORIDE
DEXTROSEActive
Strength: 5 G / 100 ML
Monograph: DEXTROSE
POTASSIUM CHLORIDEActive
Strength: 30 MG / 100 ML
Monograph: POTASSIUM CHLORIDE
SODIUM CHLORIDEActive
Strength: 600 MG / 100 ML
Monograph: SODIUM CHLORIDE
SODIUM LACTATEActive
Strength: 310 MG / 100 ML
Monograph: SODIUM LACTATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.